- Home
- PANW vs PFE Comparison
PANW vs PFE Comparison
Compare PANW & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANW
- PFE
- Stock Information
- Founded
- PANW 2005
- PFE 1849
- Country
- PANW United States
- PFE United States
- Employees
- PANW N/A
- PFE N/A
- Industry
- PANW Computer peripheral equipment
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- PANW Technology
- PFE Health Care
- Exchange
- PANW Nasdaq
- PFE Nasdaq
- Market Cap
- PANW 124.9B
- PFE 134.2B
- IPO Year
- PANW 2012
- PFE N/A
- Fundamental
- Price
- PANW $194.86
- PFE $23.46
- Analyst Decision
- PANW Buy
- PFE Hold
- Analyst Count
- PANW 46
- PFE 14
- Target Price
- PANW $207.22
- PFE $29.92
- AVG Volume (30 Days)
- PANW 5.8M
- PFE 44.8M
- Earning Date
- PANW 05-20-2025
- PFE 04-29-2025
- Dividend Yield
- PANW N/A
- PFE 7.33%
- EPS Growth
- PANW N/A
- PFE N/A
- EPS
- PANW 1.74
- PFE 1.38
- Revenue
- PANW $8,874,700,000.00
- PFE $62,464,000,000.00
- Revenue This Year
- PANW $16.46
- PFE N/A
- Revenue Next Year
- PANW $14.87
- PFE N/A
- P/E Ratio
- PANW $111.98
- PFE $16.96
- Revenue Growth
- PANW 13.90
- PFE 11.65
- 52 Week Low
- PANW $142.01
- PFE $20.92
- 52 Week High
- PANW $208.39
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- PANW 60.94
- PFE 52.45
- Support Level
- PANW $182.89
- PFE $23.11
- Resistance Level
- PANW $189.84
- PFE $23.62
- Average True Range (ATR)
- PANW 4.11
- PFE 0.46
- MACD
- PANW -0.26
- PFE 0.10
- Stochastic Oscillator
- PANW 96.66
- PFE 86.13
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.